Bio-Rad Laboratories (NYSE:BIO) is a global life science research and clinical diagnostics company headquartered in Hercules, California. Founded in 1952, the company develops, manufactures and sells products that support scientific research, biotechnology production, medical testing and quality assurance.
Its Life Science segment provides instruments, reagents, consumables and software used in areas such as genomics, proteomics, cell biology, digital PCR, electrophoresis, chromatography and biopharmaceutical manufacturing. Bio-Rad also supplies food and beverage testing products designed to help laboratories identify contaminants and verify product quality.
Through its Clinical Diagnostics segment, Bio-Rad offers systems, reagents and quality-control products for blood typing and transfusion testing, diabetes monitoring, infectious-disease testing, autoimmune diagnostics and other laboratory applications. The company serves research institutions, hospitals, clinical laboratories, biotechnology and pharmaceutical companies, and food manufacturers through operations and distribution networks in markets around the world.
